vs

Side-by-side financial comparison of CME Group (CME) and Xerox Holdings Corp (XRX). Click either name above to swap in a different company.

Xerox Holdings Corp is the larger business by last-quarter revenue ($2.0B vs $1.9B, roughly 1.1× CME Group). On growth, Xerox Holdings Corp posted the faster year-over-year revenue change (25.7% vs 14.5%). Over the past eight quarters, Xerox Holdings Corp's revenue compounded faster (16.2% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Xerox Corporation is an American corporation that sells printers, digital document products and services in more than 160 countries. Xerox was the pioneer of the photocopier market, beginning with the introduction of the Xerox 914 in 1959, so much so that the word xerox is commonly used as a synonym for photocopy. Xerox is headquartered in Norwalk, Connecticut, though it is incorporated in New York with its largest group of employees based around Rochester, New York, where the company was fou...

CME vs XRX — Head-to-Head

Bigger by revenue
XRX
XRX
1.1× larger
XRX
$2.0B
$1.9B
CME
Growing faster (revenue YoY)
XRX
XRX
+11.2% gap
XRX
25.7%
14.5%
CME
Faster 2-yr revenue CAGR
XRX
XRX
Annualised
XRX
16.2%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
XRX
XRX
Revenue
$1.9B
$2.0B
Net Profit
$1.2M
Gross Margin
Operating Margin
0.1%
Net Margin
0.1%
Revenue YoY
14.5%
25.7%
Net Profit YoY
20.7%
EPS (diluted)
$-0.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
XRX
XRX
Q1 26
$1.9B
Q4 25
$1.6B
$2.0B
Q3 25
$1.5B
$2.0B
Q2 25
$1.7B
$1.6B
Q1 25
$1.6B
$1.5B
Q4 24
$1.5B
$1.6B
Q3 24
$1.6B
$1.5B
Q2 24
$1.5B
$1.6B
Net Profit
CME
CME
XRX
XRX
Q1 26
$1.2M
Q4 25
$1.2B
Q3 25
$908.0M
$-760.0M
Q2 25
$1.0B
$-106.0M
Q1 25
$956.2M
$-90.0M
Q4 24
$874.6M
Q3 24
$912.8M
$-1.2B
Q2 24
$883.2M
$18.0M
Operating Margin
CME
CME
XRX
XRX
Q1 26
0.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
CME
CME
XRX
XRX
Q1 26
0.1%
Q4 25
71.7%
Q3 25
59.1%
-38.8%
Q2 25
60.6%
-6.7%
Q1 25
58.2%
-6.2%
Q4 24
57.3%
Q3 24
57.6%
-78.9%
Q2 24
57.6%
1.1%
EPS (diluted)
CME
CME
XRX
XRX
Q1 26
Q4 25
$3.24
$-0.62
Q3 25
$2.49
$-6.01
Q2 25
$2.81
$-0.87
Q1 25
$2.62
$-0.75
Q4 24
$2.40
$-0.21
Q3 24
$2.50
$-9.71
Q2 24
$2.42
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
XRX
XRX
Cash + ST InvestmentsLiquidity on hand
$2.4B
$512.0M
Total DebtLower is stronger
$3.4B
$4.0B
Stockholders' EquityBook value
$444.0M
Total Assets
$202.0B
$9.8B
Debt / EquityLower = less leverage
9.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
XRX
XRX
Q1 26
$2.4B
Q4 25
$4.5B
$512.0M
Q3 25
$2.6B
$479.0M
Q2 25
$2.1B
$449.0M
Q1 25
$1.5B
$336.0M
Q4 24
$3.0B
$576.0M
Q3 24
$2.4B
$521.0M
Q2 24
$1.9B
$485.0M
Total Debt
CME
CME
XRX
XRX
Q1 26
$3.4B
Q4 25
$4.0B
Q3 25
$4.1B
Q2 25
$3.5B
Q1 25
$2.7B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$3.2B
Stockholders' Equity
CME
CME
XRX
XRX
Q1 26
Q4 25
$28.7B
$444.0M
Q3 25
$28.2B
$365.0M
Q2 25
$27.7B
$1.1B
Q1 25
$27.0B
$1.1B
Q4 24
$26.5B
$1.1B
Q3 24
$28.2B
$1.3B
Q2 24
$27.6B
$2.4B
Total Assets
CME
CME
XRX
XRX
Q1 26
$202.0B
Q4 25
$198.4B
$9.8B
Q3 25
$187.1B
$10.1B
Q2 25
$179.9B
$8.9B
Q1 25
$157.8B
$8.2B
Q4 24
$137.4B
$8.4B
Q3 24
$137.8B
$8.3B
Q2 24
$123.4B
$9.5B
Debt / Equity
CME
CME
XRX
XRX
Q1 26
Q4 25
9.05×
Q3 25
11.10×
Q2 25
3.11×
Q1 25
2.56×
Q4 24
2.62×
Q3 24
2.11×
Q2 24
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
XRX
XRX
Operating Cash FlowLast quarter
$208.0M
Free Cash FlowOCF − Capex
$192.0M
FCF MarginFCF / Revenue
9.5%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$187.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
XRX
XRX
Q1 26
Q4 25
$1.1B
$208.0M
Q3 25
$968.1M
$116.0M
Q2 25
$1.1B
$-11.0M
Q1 25
$1.1B
$-89.0M
Q4 24
$1.0B
$351.0M
Q3 24
$1.0B
$116.0M
Q2 24
$776.9M
$123.0M
Free Cash Flow
CME
CME
XRX
XRX
Q1 26
Q4 25
$1.1B
$192.0M
Q3 25
$949.7M
$104.0M
Q2 25
$1.0B
$-15.0M
Q1 25
$1.1B
$-94.0M
Q4 24
$991.7M
$346.0M
Q3 24
$973.2M
$108.0M
Q2 24
$758.7M
$117.0M
FCF Margin
CME
CME
XRX
XRX
Q1 26
Q4 25
66.8%
9.5%
Q3 25
61.8%
5.3%
Q2 25
61.5%
-1.0%
Q1 25
67.1%
-6.5%
Q4 24
65.0%
21.5%
Q3 24
61.4%
7.1%
Q2 24
49.5%
7.4%
Capex Intensity
CME
CME
XRX
XRX
Q1 26
Q4 25
2.0%
0.8%
Q3 25
1.2%
0.6%
Q2 25
1.1%
0.3%
Q1 25
0.9%
0.3%
Q4 24
1.7%
0.3%
Q3 24
1.9%
0.5%
Q2 24
1.2%
0.4%
Cash Conversion
CME
CME
XRX
XRX
Q1 26
Q4 25
0.96×
Q3 25
1.07×
Q2 25
1.03×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×
6.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

XRX
XRX

Other$596.0M29%
Manufactured Product Other$485.0M24%
Supplies Paper And Other Sales$483.0M24%
IT Solutions Segment$155.0M8%
CA$128.0M6%
IT Products$100.0M5%
Rental And Other$52.0M3%
Financial Service$29.0M1%

Related Comparisons